Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mokrane Yacoub

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Annales De Pathologie|August 12, 2003
[Non tuberculous mycobacterial diseases]Homa Adle-Biassette, Michel Huerre, Guillaume Breton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
Comparison of <sup>68</sup>Ga-PSMA-617 PET/CT and <sup>68</sup>Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II StudyRomain Schollhammer, Grégoire Robert, Julien Asselineau, et al.
Plos One|July 8, 2026
Multimodal imaging to analyze the biomechanical properties of kidney tumors, evaluating feasibility, inter-modality correspondence, and diagnostic value (UroCCR-115)Mattia Ronca, Paolo Conforti, Amandine Crombé, et al.
Frontiers in Immunology|April 11, 2019
Antigenic Mimicry in Paraneoplastic Immune ThrombocytopeniaGuillaume Vial, Etienne Rivière, Anne-Aurélie Raymond, et al.
The American Journal of Surgical Pathology|March 11, 2026
Urinary Bladder Leiomyomas: A Clinicopathological Series With Hormone Receptor, HMGA2, 2SC, and Fumarate Hydratase Status AssessmentRaul E Perret, Melissa Hruby, Carina A Dehner, et al.
Pediatric Blood & Cancer|August 15, 2022
ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registryJean Donadieu, Fares Bou Mitri, Blandine Beaupain, et al.
Clinical Genitourinary Cancer|March 7, 2019
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 ExpressionSolène-Florence Kammerer-Jacquet, Angelique Brunot, Mathilde Lefort, et al.
Targeted Oncology|May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line TherapySolène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
Urologic Oncology|June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatmentSolène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Annales De Pathologie|August 12, 2003
[Non tuberculous mycobacterial diseases]Homa Adle-Biassette, Michel Huerre, Guillaume Breton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
Comparison of <sup>68</sup>Ga-PSMA-617 PET/CT and <sup>68</sup>Ga-RM2 PET/CT in Patients with Localized Prostate Cancer Who Are Candidates for Radical Prostatectomy: A Prospective, Single-Arm, Single-Center, Phase II StudyRomain Schollhammer, Grégoire Robert, Julien Asselineau, et al.
Plos One|July 8, 2026
Multimodal imaging to analyze the biomechanical properties of kidney tumors, evaluating feasibility, inter-modality correspondence, and diagnostic value (UroCCR-115)Mattia Ronca, Paolo Conforti, Amandine Crombé, et al.
Frontiers in Immunology|April 11, 2019
Antigenic Mimicry in Paraneoplastic Immune ThrombocytopeniaGuillaume Vial, Etienne Rivière, Anne-Aurélie Raymond, et al.
The American Journal of Surgical Pathology|March 11, 2026
Urinary Bladder Leiomyomas: A Clinicopathological Series With Hormone Receptor, HMGA2, 2SC, and Fumarate Hydratase Status AssessmentRaul E Perret, Melissa Hruby, Carina A Dehner, et al.
Pediatric Blood & Cancer|August 15, 2022
ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registryJean Donadieu, Fares Bou Mitri, Blandine Beaupain, et al.
Clinical Genitourinary Cancer|March 7, 2019
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 ExpressionSolène-Florence Kammerer-Jacquet, Angelique Brunot, Mathilde Lefort, et al.
Targeted Oncology|May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line TherapySolène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
Urologic Oncology|June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatmentSolène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
Pageof 4